Westat call order# 8 for technical support for seer and cancer control and population based research. Period of performance 9/16/20 - 8/15/21

Ended Awarded Last action

Contract number
75N91020F00199
Awardee
Awarding agency
Obligated
$1,338,084

Award facts

Contract value 100% obligated
$1,338,084.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541611 Administrative Management and General Management Consulting Services
PSC
R410 Support- Professional: Program Evaluation/Review/Development
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Rockville, MD 20850, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute awarded Westat, Inc. a call order valued at $1.34M under a Blanket Purchase Agreement (BPA) for technical support related to the Surveillance, Epidemiology, and End Results (SEER) program and cancer control and population-based research. Performed from September 16, 2020 through August 15, 2021, this firm fixed-price contract deliverable encompasses professional support services for cancer surveillance activities and surveillance research. The work was performed at Westat's location in Potomac, Maryland. This award was not designated with a small business set-aside, reflecting Westat's established position as a large, experienced government contractor capable of handling complex research initiatives.

Westat, Inc., a Rockville, Maryland-based professional services firm founded in 1963, specializes in research, technical assistance, data collection, analysis, and evaluation services for federal agencies. The company brings substantial expertise in public health research and cancer surveillance through its extensive track record with the National Institutes of Health, Centers for Disease Control and Prevention, and other federal health agencies. This call order represents part of Westat's broader engagement supporting the NCI's cancer surveillance and epidemiological research mission, leveraging the company's sophisticated capabilities in survey research, statistical analysis, and program evaluation to advance national cancer control efforts.

Quick answers

Who was awarded contract 75N91020F00199?

75N91020F00199 was awarded to Westat, Inc. by National Cancer Institute (National Institutes of Health) on September 16, 2020.

How much is contract 75N91020F00199 worth?

The government has obligated $1,338,084 on 75N91020F00199.

Is contract 75N91020F00199 an order under another contract?

Yes. 75N91020F00199 is a BPA call under GS00F009DA-HHSN261201600004B, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 75N91020F00199 competed?

The extent of competition for 75N91020F00199 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award